Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

N/ACompletedNCT02025894

Institut de Cancérologie de la Loire3,032 enrolled

Overview

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

Study Type

OBSERVATIONAL

Enrollment

3,032

Conditions

Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient with a neoplastic solid tumour with an indication for insertion of a PCVC. Exclusion Criteria: * Haematological neoplasm pathology, PCVC removal scheduled within 2 weeks of insertion, * Therapeutic doses of anticoagulants required at inclusion, * PCVC inserted by the femoral vein

Locations (27)

CH d'Annecy

Annecy, France, France

Outcomes

Primary Outcomes

Thromboembolic complications:

Time frame: one year

Locoregional or disseminated infectious complications:

Time frame: one year

Secondary Outcomes

Medical and economic consequences of these complications

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.